Takeda unveils profit surprise on Shire integration—and no U.S. Natpara supply till 2021

4th February 2020 Uncategorised 0

Takeda had expected to report an operating loss this fiscal year. But thanks to faster integration with Shire, it’s now looking at a possible profit. Don’t expect any contribution from Natpara in the U.S., though, Takeda’s chief financial officer said—the rare disease med won’t be available until March 2021 at the earliest.

More: Takeda unveils profit surprise on Shire integration—and no U.S. Natpara supply till 2021
Source: fierce